Thrivent Financial for Lutherans’s Innospec IOSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.21M | Sell |
16,539
-487
| -3% | -$37.9K | ﹤0.01% | 1775 |
|
|
2025
Q4 | $1.3M | Sell |
17,026
-889
| -5% | -$67.1K | ﹤0.01% | 1751 |
|
|
2025
Q3 | $1.38M | Sell |
17,915
-17,842
| -50% | -$1.49M | ﹤0.01% | 1573 |
|
|
2025
Q2 | $3.01M | Sell |
35,757
-742
| -2% | -$65K | 0.01% | 1089 |
|
|
2025
Q1 | $3.46M | Sell |
36,499
-959
| -3% | -$101K | 0.01% | 976 |
|
|
2024
Q4 | $4.12M | Sell |
37,458
-22,144
| -37% | -$2.53M | 0.01% | 994 |
|
|
2024
Q3 | $6.74M | Buy |
59,602
+195
| +0.3% | +$22.7K | 0.01% | 806 |
|
|
2024
Q2 | $7.34M | Sell |
59,407
-5,215
| -8% | -$653K | 0.01% | 756 |
|
|
2024
Q1 | $8.33M | Sell |
64,622
-586
| -0.9% | -$71.2K | 0.02% | 715 |
|
|
2023
Q4 | $8.04M | Sell |
65,208
-3,133
| -5% | -$333K | 0.02% | 703 |
|
|
2023
Q3 | $6.98M | Sell |
68,341
-1,043
| -2% | -$109K | 0.02% | 699 |
|
|
2023
Q2 | $6.97M | Sell |
69,384
-2,386
| -3% | -$239K | 0.02% | 739 |
|
|
2023
Q1 | $7.37M | Sell |
71,770
-4,428
| -6% | -$477K | 0.02% | 685 |
|
|
2022
Q4 | $7.84M | Sell |
76,198
-18,658
| -20% | -$1.89M | 0.02% | 666 |
|
|
2022
Q3 | $8.13M | Sell |
94,856
-2,831
| -3% | -$267K | 0.02% | 655 |
|
|
2022
Q2 | $9.36M | Sell |
97,687
-14,012
| -13% | -$1.36M | 0.02% | 632 |
|
|
2022
Q1 | $10.3M | Buy |
111,699
+6
| +0% | +$568 | 0.02% | 675 |
|
|
2021
Q4 | $10.1M | Sell |
111,693
-17,211
| -13% | -$1.52M | 0.02% | 669 |
|
|
2021
Q3 | $10.9M | Sell |
128,904
-149,626
| -54% | -$13.3M | 0.02% | 645 |
|
|
2021
Q2 | $25.2M | Buy |
278,530
+2,231
| +0.8% | +$221K | 0.05% | 394 |
|
|
2021
Q1 | $28.4M | Sell |
276,299
-14,780
| -5% | -$1.46M | 0.06% | 356 |
|
|
2020
Q4 | $26.4M | Buy |
291,079
+139,371
| +92% | +$10.8M | 0.06% | 382 |
|
|
2020
Q3 | $9.61M | Sell |
151,708
-14,734
| -9% | -$1.09M | 0.03% | 609 |
|
|
2020
Q2 | $12.9M | Buy |
166,442
+28
| +0% | +$2.05K | 0.04% | 490 |
|
|
2020
Q1 | $11.6M | Sell |
166,414
-39,340
| -19% | -$3.59M | 0.04% | 469 |
|
|
2019
Q4 | $21.3M | Buy |
205,754
+32,246
| +19% | +$3.08M | 0.06% | 362 |
|
|
2019
Q3 | $15.5M | Sell |
173,508
-1,421
| -0.8% | -$127K | 0.05% | 386 |
|
|
2019
Q2 | $16M | Buy |
174,929
+422
| +0.2% | +$35.6K | 0.05% | 386 |
|
|
2019
Q1 | $14.5M | Sell |
174,507
-1,064
| -0.6% | -$79.3K | 0.05% | 385 |
|
|
2018
Q4 | $10.8M | Buy |
175,571
+4,091
| +2% | +$281K | 0.04% | 424 |
|
|
2018
Q3 | $13.2M | Sell |
171,480
-1,549
| -0.9% | -$121K | 0.04% | 423 |
|
|
2018
Q2 | $13.2M | Buy |
173,029
+320
| +0.2% | +$24K | 0.04% | 415 |
|
|
2018
Q1 | $11.8M | Sell |
172,709
-23,026
| -12% | -$1.6M | 0.04% | 424 |
|
|
2017
Q4 | $13.8M | Sell |
195,735
-14,602
| -7% | -$973K | 0.05% | 374 |
|
|
2017
Q3 | $13M | Buy |
210,337
+60,449
| +40% | +$3.62M | 0.05% | 354 |
|
|
2017
Q2 | $9.82M | Buy |
149,888
+3,030
| +2% | +$195K | 0.04% | 404 |
|
|
2017
Q1 | $9.51M | Buy |
146,858
+76,680
| +109% | +$5.13M | 0.04% | 406 |
|
|
2016
Q4 | $4.81M | Buy |
70,178
+680
| +1% | +$43.7K | 0.02% | 583 |
|
|
2016
Q3 | $4.23M | Sell |
69,498
-6,080
| -8% | -$338K | 0.02% | 645 |
|
|
2016
Q2 | $3.48M | Sell |
75,578
-24,880
| -25% | -$1.18M | 0.02% | 712 |
|
|
2016
Q1 | $4.36M | Sell |
100,458
-22,730
| -18% | -$1.05M | 0.02% | 646 |
|
|
2015
Q4 | $6.69M | Buy |
+123,188
| New | +$6.8M | 0.03% | 465 |
|
Other funds holding IOSP
VPM
VCM
N
Thrivent Financial for Lutherans's IOSP Position: Q1 2026 in Review
Thrivent Financial for Lutherans reduced its Innospec (IOSP) stake by 2.9% in Q1 2026, selling an estimated $37.9K and leaving 16,539 shares worth $1.21M. The position accounts for ﹤0.01% of the portfolio, ranked #1775.
Thrivent Financial for Lutherans first reported a position in IOSP in Q4 2015 and has held it in 42 quarters since. The position peaked at $28.4M in Q1 2021. 266 funds tracked by Wall St. Rank hold IOSP as of Q1 2026.
- Thrivent Financial for Lutherans held 16,539 shares of Innospec worth $1.21M as of Q1 2026.
- Thrivent Financial for Lutherans sold 487 Innospec shares in Q1 2026, an estimated $37.9K.
- Innospec made up ﹤0.01% of Thrivent Financial for Lutherans's portfolio in Q1 2026, its #1775 holding.
- Thrivent Financial for Lutherans first reported a position in Innospec in Q4 2015 and has held it in 42 quarters since.
- Thrivent Financial for Lutherans's Innospec position peaked at $28.4M in Q1 2021.
- 266 funds tracked by Wall St. Rank held Innospec as of Q1 2026.
Based on Thrivent Financial for Lutherans's 13F filing for Q1 2026, filed 1 May 2026.